International, Randomized, Placebo-Controlled Trial Of Cc-486 (Oral Azacitidine) In Patients With Ipss Intermediate-1 Myelodysplastic Syndromes With Rbc-Transfusion-Dependent Anemia And Thrombocytopenia: The Quazar Lower-Risk Mds Trial

AuthID
P-00P-BTY
13
Author(s)
Garcia Manero, G
·
Platzbecker, U
·
Santini, V
·
Voso, MT
·
Garcia, R
·
Valcarcel, D
·
Silverman, LR
·
Giagounidis, A
·
Larsen, SR
·
Kreitz, S
·
Hoenekopp, A
·
Skikne, BS
Tipo de Documento
Abstract
Year published
2015
Publicado
in LEUKEMIA RESEARCH, ISSN: 0145-2126
Volume: 39, Páginas: S51-S52 (2)
Conference
13Th International Symposium on Myelodysplastic Syndromes (Mds), Date: APR 29-MAY 02, 2015, Location: Washington, DC
Indexing
Publication Identifiers
Wos: WOS:000373183500101
Source Identifiers
ISSN: 0145-2126
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.